Total Payments
$23,516
2024 Payments
$4,180
Companies
40
Transactions
830
Medicare Patients
6,694
Medicare Billing
$765,001
Payment Breakdown by Category
Food & Beverage$21,996 (93.5%)
Consulting$1,000 (4.3%)
Education$520.09 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,996 | 821 | 93.5% |
| Consulting Fee | $1,000 | 1 | 4.3% |
| Education | $520.09 | 8 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $6,000 | 210 | $0 (2024) |
| Lilly USA, LLC | $3,808 | 115 | $0 (2024) |
| Allergan, Inc. | $2,715 | 56 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,676 | 75 | $0 (2024) |
| Janssen Biotech, Inc. | $1,234 | 53 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,094 | 42 | $0 (2024) |
| PFIZER INC. | $989.40 | 39 | $0 (2024) |
| UCB, Inc. | $885.91 | 42 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $835.56 | 33 | $0 (2024) |
| Genentech USA, Inc. | $781.70 | 47 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,180 | 154 | ABBVIE INC. ($1,085) |
| 2023 | $3,351 | 127 | ABBVIE INC. ($968.31) |
| 2022 | $3,658 | 117 | ABBVIE INC. ($924.76) |
| 2021 | $1,753 | 89 | AbbVie Inc. ($352.42) |
| 2020 | $1,518 | 76 | AbbVie Inc. ($401.80) |
| 2019 | $4,020 | 122 | Allergan Inc. ($1,725) |
| 2018 | $2,402 | 72 | AbbVie, Inc. ($766.18) |
| 2017 | $2,633 | 73 | AbbVie, Inc. ($840.73) |
All Payment Transactions
830 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Immunology | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $74.99 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.90 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $100.61 | General |
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $92.32 | General |
| 11/19/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Immunology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.21 | General |
| Category: Immunology | ||||||
| 11/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $73.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Dermatology | ||||||
| 11/11/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,675 | 2,525 | $904,854 | $198,332 |
| 2022 | 30 | 1,819 | 2,861 | $332,286 | $207,039 |
| 2021 | 26 | 1,537 | 2,441 | $253,681 | $161,916 |
| 2020 | 28 | 1,663 | 2,693 | $310,917 | $197,714 |
Total Patients
6,694
Total Services
10,520
Medicare Billing
$765,001
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 585 | 1,090 | $211,275 | $53,375 | 25.3% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 230 | 308 | $176,926 | $37,353 | 21.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 181 | 222 | $110,419 | $22,239 | 20.1% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 133 | 150 | $78,938 | $16,399 | 20.8% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 41 | 43 | $56,585 | $14,877 | 26.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 46 | 49 | $41,405 | $10,136 | 24.5% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 52 | 60 | $32,302 | $7,166 | 22.2% |
| 17283 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 31 | 41 | $27,893 | $6,379 | 22.9% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 61 | 67 | $49,904 | $6,323 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 74 | $18,754 | $4,254 | 22.7% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 17 | 17 | $14,955 | $3,568 | 23.9% |
| 17273 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 24 | 25 | $14,573 | $3,451 | 23.7% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 29 | 30 | $15,016 | $2,757 | 18.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 31 | 35 | $9,837 | $2,160 | 22.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $12,925 | $1,732 | 13.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 47 | $7,455 | $1,647 | 22.1% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 14 | 14 | $12,292 | $1,630 | 13.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 31 | 35 | $6,544 | $1,197 | 18.3% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 21 | 21 | $2,394 | $638.20 | 26.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 25 | 123 | $2,288 | $566.72 | 24.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 55 | $2,176 | $487.14 | 22.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 693 | 1,365 | $91,434 | $60,982 | 66.7% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 192 | 234 | $46,864 | $30,194 | 64.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 135 | 167 | $29,242 | $16,723 | 57.2% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 45 | 46 | $20,840 | $15,641 | 75.1% |
About Charles Fulk
Charles Fulk is a Specialist healthcare provider based in Morristown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801848668.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Charles Fulk has received a total of $23,516 in payments from pharmaceutical and medical device companies, with $4,180 received in 2024. These payments were reported across 830 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($21,996).
As a Medicare-enrolled provider, Fulk has provided services to 6,694 Medicare beneficiaries, totaling 10,520 services with total Medicare billing of $765,001. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Morristown, TN
- Active Since 05/17/2006
- Last Updated 01/02/2015
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1801848668
Products in Payments
- TALTZ (Drug) $2,682
- Humira (Biological) $1,364
- SKYRIZI (Biological) $1,316
- COSENTYX (Biological) $1,194
- EUCRISA (Drug) $970.12
- TREMFYA (Drug) $851.65
- Sotyktu (Drug) $835.56
- Erivedge (Biological) $760.01
- RINVOQ (Biological) $618.19
- HUMIRA (Biological) $494.60
- ILUMYA (Biological) $490.13
- DUPIXENT (Biological) $473.36
- Cimzia (Drug) $455.54
- OLUMIANT (Drug) $454.10
- Tremfya (Drug) $427.35
- BOTOX (Biological) $398.69
- COSENTYX (Drug) $344.79
- Bimzelx (Biological) $337.92
- Skyrizi (Biological) $290.97
- Odomzo (Drug) $286.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Morristown
Lowell Kabnick, M.d, M.D
Specialist — Payments: $2.2M
Specialist $2.2M
Dr. Matthew Iammatteo, M.d, M.D
Specialist — Payments: $32,919
Specialist $32,919
Andrew Willis, M.d, M.D
Specialist — Payments: $21,613
Specialist $21,613
Michael Goldberger
Specialist — Payments: $6,007
Specialist $6,007
Dr. George Naseef, M.d, M.D
Specialist — Payments: $5,826
Specialist $5,826
Charles Gatto, M.d, M.D
Specialist — Payments: $4,128
Specialist $4,128